Thalassaemia is one of the most common genetic disorders in Southeast Asian countries. It is a major health problem in Malaysia with a recent reported carrier rate of about 6.8%.
Patients with β-thalassaemia major (TM) require lifelong transfusion while patients with thalassaemia intermedia (TI) generally do not need regular blood transfusions but may still require medical attention at the later part of life due to complications of iron overload.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.
